Skip to main content

Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness



To evaluate the Oxford Knee Score (OKS), EQ-5D-5L utility index and EQ-5D visual analogue scale (EQ-VAS) for health-related quality of life outcome measurement in patients undergoing elective total knee arthroplasty (TKA) surgery.


In this prospective multi-centre study, the OKS and EQ-5D-5L index scores were collected preoperatively, six weeks (6w) and six months (6 m) following TKA. The OKS, EQ-VAS and EQ-5D-5L index were evaluated for minimally important difference (MID), concurrent validity, predictive validity (Spearman's Rho of predicted and observed values from a generalised linear regression model (GLM)), responsiveness (effect size (ES) and standard response mean (SRM)). The MID for the individual patient was determined utilising two approaches; distribution-based and anchor-based.


533 patients were analysed. The EQ-5D-5L utility index showed good concurrent validity with the OKS (r = 0.72 preoperatively, 0.65 at 6w and 0.69 at 6 m). Predictive validity for the EQ-5D-5L index was lower than OKS when regressed. Responsiveness was large for all fields at 6w for the EQ-5D-5L and OKS (EQ-5D-5L ES 0.87, SRM 0.84; OKS ES 1.35, SRM 1.05) and 6 m (EQ-5D-5L index ES 1.31, SRM 0.95; OKS ES 1.69, SRM 1.59). The EQ-VAS returned poorer results, at 6w an ES of 0.37 (small) and SRM of 0.36 (small). At 6 m, the EQ-VAS had an ES of 0.59 (moderate) and SRM of 0.47 (small). It, however, had similar predictive validity to the OKS, and better than the EQ-5D-5L index. MID determined using anchor approach, was shown that for OKS at 6 weeks it was 8.84 ± 9.28 and at 6 months 13.37 ± 9.89. For the EQ-5D-5L index at 6 weeks MID was 0.23 ± 0.39, and at 6 months 0.26 ± 0.36.


The EQ-5D-5L index score and the OKS demonstrate good concurrent validity. The EQ-5D-5L index demonstrated lower predictive validity at 6w, and 6 m than the OKS, and both PROMs had adequate responsiveness. The EQ-VAS had poorer responsiveness but better predictive validity than the EQ-5D-5L index.

This article includes MID estimates for the Australian knee arthroplasty population.


Total knee arthroplasty (TKA) is a safe and cost-effective surgery for patients with osteoarthritis who do not respond to medical therapy alone [1] and in Australia, a total of 54,102 replacements were performed per year from 2017 – 2018 (218 per 100,000). [2] Despite the well-established safety data and patient improvements published over the last 20 years [1], the measurement of patient-related outcomes, including functional change or improvement, are not as clear-cut for TKA compared to other orthopaedic surgery such as total hip arthroplasty. [3, 4].

Patient-reported outcome measures (PROMS) are used as a measurement tool to evaluate patient and health economic outcomes, with an example being the 5-level version of the EuroQol 5 Dimensions (EQ-5D-5L index score). This standardized health-related quality of life (HRQoL) questionnaire was initially developed in 1990 as a 3-level version designed to assess general health for five dimensions. [5, 6] In 2011, it was revised to a 5-level version (EQ-5D-5L index) with five levels and five dimensions to reduce granularity in health response and reduce the ceiling effect. [7] The EQ-5D questionnaires are some of the most widely used PROMs globally; in some countries, such as the United Kingdom, it is used to calculate quality adjusted life years used in cost-utility analysis [8,9,10].

While extensively used in other parts of the world, the EQ-5D-5L index score has not yet been well validated for the Australian orthopaedic population for HRQoL assessment. [11] The results of the EQ-5D-5L index score PROM are converted into vectors which are five-digit codes representing a health state. For example, 11,111 is full health, and 55,555 represents the worst health. There are 3,125 possible health states. These are mapped onto a single utility index using a country-specific value set. To date, more than 25 countries have validated country-specific EQ-5D-5L value sets for various patient populations. [12].

The EQ-VAS is a stand-alone component of the EQ-5D-5L index, in which a patient self-reports their impression of their general health and functionality. Compared with the in-depth, question-and-answer format of the ED-5D-5L index, the EQ-VAS is seen as a simpler and less ambiguous format. [13] The Oxford Knee Score (OKS) is a validated PROM specifically developed to assess function and pain in patients undergoing TKA. [14] It had been utilised to assess the concurrent validity of the EQ-5D-5L index in TKA patients in other countries. [15].

The minimally important difference is defined as the smallest PROM score change, which is perceived significantly by patients or clinicians. [16] The MID is 'anchored' by using a satisfaction survey to identify patients who experienced a change in their functional status considered perceptible and clinically important. Changes in functional status were measured using a five-point Likert scale at one year postoperatively scored as either (1) "very satisfied", (2) "satisfied" (3) "neither satisfied nor dissatisfied", (4) "dissatisfied", or (5) "very dissatisfied". Patients whose functional change was 4 or 2 were considered to have experienced some change equivalent to the MID. [17] It is generally considered that the anchor-based approach is the optimal method for evaluation of MID as it yields a direct expression of the patient’s preferences and values. [16] The distribution-based method of MID estimation assesses the distribution of scores around the mean of the measurement of interest, for example standard deviation. [18].

Concurrent validity describes the extent of the method being tested to assess an outcome correlates with an established method to measure the same. Here the EQ-5D-5L index will be tested against the established OKS. Predictive validity describes the association between baseline and follow-up outcomes which is highly valued in this cohort, as it has implications for surgical suitability for individual patients. Responsiveness, a measure of the sensitivity of PROMs to reflect a change in health status over time, is also tested.

Outcome measure

This study aims to compare the EQ-5D-5L utility index and EQ-VAS against the OKS in Australian patients undergoing total knee arthroplasty using the minimally important difference (MID), concurrent and predictive validity.

Patients and methods

This multi-centre prospective trial was conducted at two large tertiary teaching hospitals in Adelaide, Australia. A group of orthopaedic surgeons operate routinely at both sites, performing approximately 300 knee arthroplasty surgeries annually. However, the number of patients operated on in 2020 was reduced to approximately 150 due to SARS Covid-19-related restrictions. The local governing Human Research Ethics Committee granted multi-centre approval (SALHN/329.17).

All consecutive adult patients undergoing elective total knee arthroplasty surgery were prospectively enrolled over a nearly three-year period from 8th January 2018 to 1st of October 2020, with a six-month follow-up until 2nd April 2021. Indication for surgery was predominantly osteoarthritis, all joint replacements were primary operations only. Informed consent was obtained from all participants, and baseline demographics were recorded for all patients, including age, gender, body mass index (BMI) and the Charlson comorbidity index (CCI) [19, 20].

Data were recorded at three different time points (preoperatively, six weeks and six months postoperatively) by one dedicated research assistant, using scripted questionnaires via telephone or a written survey sent by postal mail. At all three time points, two validated PROMs were used: the Oxford Knee Score (OKS) [21] and the EQ-5D-5L index score [5] including the EQ-VAS stand-alone component. Data were keyed into a password-secured database and stored on the hospital computer network.

Patients were included for analysis if they had complete quality of life data. This was defined as completing the EQ-5D-5L index score and OKS for the three time points.

Oxford knee score

The OKS is a joint-specific PROM [22, 23] which has been extensively utilised over the last 20 years. It assesses six fields (pain, walking, physical activity, function, quality of life and psychological wellbeing), with each field containing 2 questions, making up a total of 12 questions. Each question is scored on a 5-point discrete visual analogue scale where higher scores indicate better function. The final score is a sum tally of the individual question scores, with a range of 0 to 48. The OKS has previously been utilised as a comparator for responsiveness with PROMs such as the EQ-5D-3L and SF-12 in a similar patient population, albeit in different countries than Australia. [24, 25].

EQ-5D-5L index and EQ-VAS

The EuroQol Group designed the EQ-5D-5L index to quantify general health in adults. Using a 5-point scale (none, slight, moderate, severe and extreme/unable to perform), it evaluates the fields of mobility, self-care, usual activities, anxiety/depression and pain/discomfort. Based on the general Australian population, preference weights can be attached to each of the EQ-5D-5L health states. These were determined through a discrete choice experiment approach [26]. Utility indices vary from − 0.676 to 1, with higher utilities signifying a better HRQoL.

The EQ-VAS is a vertical visual analogue scale which constitutes a part of the EQ-5D-5L index score and can also be used as a stand-alone component. Patients are to rate their general health from 0 to 100, with higher numeric scores denoting a better function. The EQ-5D-5L index questionnaire is established on specific national value sets or the generic Western Preference Pattern. [27] It has been validated in approximately 28 countries as of 2022 [28,29,30,31].

Statistical analysis

All statistical analyses were performed utilising STATA version 17 (StataCorp, Texas, USA). Continuous variables (age, BMI, CCI) were expressed as means and standard deviations. The categorical variable (gender) was expressed as percentages (counts). A p-value of < 0.05 was considered statistically significant.

Concurrent validity, predictive validity and agreement

For analysis of concurrent validity, Spearman's correlation coefficient (rho, ρ) was utilised to compare the EQ-5D-5L index and EQ-VAS against the OKS. The strength of the relationship can be assessed as low/weak (ρ < 0.25), fair (ρ = 0.25 to < 0.50), good (ρ = 0.50–0.75), or excellent (ρ > 0.75). This magnitude of rank order correlations was sourced from previous publications on the same area. [32, 33].

Predictive validity was ascertained using a regression framework, whilst controlling for confounders. We utilised generalized linear models with the 6-week and 6-month postoperative PROMs as the dependent variable, and the preoperative values and baseline characteristics as independent variables. Depending on the distribution of the dependant variable, the most appropriate distribution family and canonical link function were chosen. Multiple families (including the Gaussian, inverse Gaussian, Poisson, and Gamma distributions) were trialled when there was difficulty ascertaining the appropriate family of distribution. The best fitting model was then selected based on low Akaike's Information Criteria and Bayesian Information Criteria scores. The average marginal effect with respect to preoperative score was used to compare models if different distribution families were utilised.

The agreement between the EQ-5D-5L index and the OKS was measured using Bland–Altman analysis at all three measurement points.


Responsiveness is a measure of the sensitivity of PROMs to reflect the change in health status over time. For this study, we compared measurements at baseline, 6 weeks and 6 months follow-up using paired t-tests. Further assessment of responsiveness was quantified using effect size (ES) and standardized response mean (SRM).

The effect size was calculated using the formula: effect size equals the mean difference from baseline divided by the standard deviation at baseline.

The standard response mean was calculated using the formula: standard response mean equals mean difference from baseline divided by the standard deviation of difference.

ES and SRM were classified according to Cohen’s rule of thumb, as large (≥ 0.8), moderate (0.5–0.79) or small (< 0.5). [34] Both ES and SRM are standardized measures of change over time in health, independent of sample size.

Influence of baseline characteristics on PROMs

Regression analysis of the baseline characteristics (age, gender, BMI and CCI) was performed using generalised linear models with the preoperative EQ-5D-5L index, EQ-VAS and OKS as independent variables. The preoperative PROMs were used as the dependant variables, and depending on the distribution, an appropriate distribution family and canonical link function were chosen using the same approach taking in the predictive validity analysis. The coefficient, standard error and p-values were recorded.

Determination of minimally important difference

Minimally important difference (MID) is defined as the smallest change in score, which is perceived as important by patients or clinicians. [35] The MID for the cohorts was defined as the change in PROM score for patients who responded as satisfied [2] or dissatisfied [4] to the anchor question at one year. The MID was determined using two approaches: distribution-based approach, and the anchor-based approach.

The distribution-based approach defined MID as half the baseline standard deviation of the PROM scores [36] For both the anchor-based approach, we quantified satisfaction based on the anchor question (satisfaction rating). We then calculated Spearman's correlation coefficient to assess the correlation between the measured score and the satisfaction rating. The MID calculation would not be performed if the correlation coefficient was less than 0.25. While calculating the MID using the anchor-based approach, we considered a satisfaction score of 2 or 4 as having experienced some MID-equivalent change. The MID was then taken as the mean changes in scores of the patients who scored 2 or 4.


In total, the database had 797 patients, of which 96 were excluded as they did not have a preoperative questionnaire completed, 115 did not have any postoperative questionnaires answered, and a further 9 had their operation cancelled. There were statistically insignificant differences in characteristics between those with complete data and those with missing data for nearly all demographic characteristics. Out of 12 comparisons, only 2 statistically significant differences were seen with another borderline significant (Additional file 1: Appendix 1). Therefore, complete case analysis was conducted.

Six hundred seventy-three knee arthroplasty patients with preoperative and postoperative questionnaires completed were identified from the database. Of these, 140 had preoperative and 6w data, and the further 533 had complete data for preoperative, 6w and also 6 months. All 673 with both pre- and postoperative data were included in the study. The mean age of our cohort at the time of surgery was 68.3 ± 9.6 years old, and 59.14% (398/673) were female. The mean preoperative BMI was 31.9 ± 5.7 and the mean CCI was 72.0 ± 22.4%. A summary of baseline characteristics can be found in Table 1. Early complications of arthroplasty recorded at 6 weeks included 20 cases of venous thromboembolism, 19 cases of additional antibiotic use, eight cases of peri-prosthetic fractures, seven cases of myocardial infarctions, five cases of cerebrovascular events, four cases of postoperative stiffness limiting rehabilitation and two cases of periprosthetic infections requiring re-operation. Eleven patients had more than one complication, and 610 patients of the total 673 included reported no complications. Of the 533 patients who were followed up until 6 months, 53 of them had early complications.

Table 1 Baseline Characteristics

Boxplots for the distributions of scores at baseline (preoperative), 6 weeks and 6 months are shown in Fig. 1.

figure 1

Boxplots Showing Distribution of PROMs Scores over Time

Number of patient responses to the satisfaction survey at one year were as follows:

  • 1 (Very satisfied): 196 (48.2%)

  • 2 (Satisfied): 114 (28%)

  • 3 (Neither Satisfied Nor Dissatisfied): 62 (15.2%)

  • 4 (Dissatisfied): 24 (5.9%)

  • 5 (Very Dissatisfied): 11 (2.7%)

A summary of baseline characteristics can be found in Table 1.

Concurrent validity, predictive validity and agreement

EQ-5D-5L index showed good concurrent validity when compared to OKS at baseline, 6 weeks, and 6 months postoperative, with a Spearman's coefficient of 0.72, 0.65 and 0.69, respectively. EQ-VAS had fair concurrent validity when compared to OKS at baseline, 6 weeks, and 6 months postoperative, with a Spearman's coefficient of 0.31, 0.46 and 0.49 respectively (Table 2).

Table 2 Concurrent and Predictive Validity

Predictive validity for each of the three different PROMs score was determined using generalized linear models, with regression to baseline scores and covariates. In all cases, the distribution that provided the best model fit was the Gamma distribution with a canonical negative inverse link. The average marginal effects for the preoperative score were recorded and displayed in Table 2. The EQ-5D-5L index score showed lower predictive validity when compared to OKS at 6 weeks and 6 months. EQ-VAS, however, showed similar predictive validity compared to OKS at 6 weeks and 6 months.

Bland Altman's plot showed good agreement between OKS and EQ-5D-5L index at preoperative, 6 weeks and 6 months, with approximately 95% of data points within the limits of agreement. These plots are shown in Figs. 2, 3 and 4.

Fig. 2
figure 2

Preoperative Bland Altman Plots

Fig. 3
figure 3

Bland Altman Plots at 6 Weeks

Fig. 4
figure 4

Bland Altman Plots at 6 Months


At 6 weeks, all three PROMs showed significant differences between baseline and follow-up scores. Both OKS and EQ-5D-5L index had a large ES and SRM, although the actual estimate for OKS was larger. The ES for OKS and EQ-5D-5L index was 1.35 and 0.87, respectively, and the SRM was 1.05 and 0.84, respectively. The EQ-VAS had a small ES and SRM of 0.37 and 0.36, respectively.

At 6 months, all three PROMs again showed a significant difference between baseline and follow-up scores: The ES for OKS, EQ-5D-5L index, and EQ-VAS were 1.69, 1.31 and 0.59, respectively, and the SRM was 1.59, 0.95 and 0.47 respectively. These findings are detailed in Table 3.

Table 3 Responsiveness of PROMs

Influence of baseline characteristics on PROMs

Since EQ-5D-5L scores had negative values, it was determined that the Gaussian family of distribution with a canonical identity link was most appropriate compared to both OKS and EQ-VAS, which had non-negative distributions. Therefore, the Gamma distribution provided the best fit and was hence used for the final model. All three preoperative PROMs were significantly affected by CCI. EQ-VAS was additionally significantly affected by BMI (Table 4).

Table 4 Regression Analysis with respect to Baseline Characteristics using Preoperative PROMs as the Dependant Variables

Minimally important difference

As measured using the distribution-based method, the MID for OKS and EQ-5D-5L index were 3.70 and 0.18, respectively. When the anchor-based technique was utilised, the MID for OKS at 6 weeks and 6 months was 8.84 ± 9.28 and 13.37 ± 9.89, respectively. The MID for the EQ-5D-5L index scores were 0.23 ± 0.39 and 0.26 ± 0.36 at 6 weeks and 6 months, respectively (Table 5).

Table 5 Minimum Important Difference (MID)


This analysis is an empirical validation of the EQ-5D-5L index’s suitability in assessing HRQoL amongst knee arthroplasty patients using experienced-based patient data from a prospective multi-centre study database, with the correlation between the Oxford Knee Scores, EQ-VAS, and the EQ-5D-5L index PROMs. The findings support the utilization of the EQ-5D-5L index as a valid and reliable instrument in assessing HRQoL amongst these patients, but it must be noted that the OKS outperformed the EQ-5D-5L index in all fields. The EQ-VAS had poorer responsiveness than the EQ-5D-5L index, but better predictive validity.

The EQ-VAS as a stand-alone measure showed a smaller ES than the EQ-5D-5L index at both six weeks (0.37 versus 0.87 respectively, p < 0.0001) and six months (0.59 versus 1.31 respectively, p < 0.0001). The SRM was large for the EQ-5D-5L index score at the six-week and six-month time points, but only small for the EQ-VAS. However, the EQ-VAS had better predictive validity than the EQ-5D-5L index but comparable validity to the OKS. This suggests a higher predictive value for postoperative recovery and could be used as an adjunct to the EQ-5D-5L index score. An explanation for this may be the broader nature of the EQ-VAS (ie. not proscribed by the domains or items as in the OKS or EQ-5D-5L index descriptive system), which allows the patients to consider more quality of life constructs in their subjective rating of health. This is beneficial for patient stratification and counselling regarding realistic rehabilitation expectations and postsurgical results.

The EQ-VAS standalone component was only fair in terms of concurrent validity. The OKS is a joint-specific PROM, whereas the EQ-5D-5L index is designed to assess overall functionality. For example, someone who can compensate enough to perform daily tasks and cope well with the mental burden of an arthritic knee on the EQ-5D-5L index, may record gait disturbances and set specific difficulties with mobility on the OKS. We chose the OKS as a comparator for this validation as it is widely used and has significant items that overlap with the EQ-5D-5L index. For example, both feature mobility, pain/discomfort and usual activities. Hence, they should be utilised concurrently to complement each other, instead of being considered as substitutes for one another.

This study analysed MID via two approaches; anchor-based and distribution-based. An estimate of MID in this patient population is important clinically as it will indicate when a particular patient would notice a benefit from knee arthroplasty surgery. It is important in study design, as any new treatment being investigated should aim to detect a difference at least equal to the MID. Non-inferiority studies should aim to show that the difference between groups is less than the MID for the Australian orthopaedic population. [37].

The longitudinal nature of this study with multiple time points allows evaluation of the incremental changes in the population and the differences in the performance of both PROMs. The experience-based and prospective nature of this data is also a strong point.

Generalizability of this study is high, as surgical technique and perioperative management is consistent with standard practice in Australia, and worldwide.

The EQ-5D-5L index has been assessed against other PROMs in the TKA population in previous publications, and found to to be more responsive (ES and SRM) than other scores in reflecting health related changes in this group. [38] Conner-Spady et al. found a MID of 0.20 for TKA patients for the EQ-5D-5L index. [15] They reported a wide variation in the MID with the percentage agreement of responder classification using 2SEM versus MID ranging from 79.6 to 99.6% for the EQ-5D-5L and from 69.4 to 94.8% for the Oxford scores. Recommendations included utilising multiple PROMs for HRQoL assessment in future studies. Our study also found a wide variation, with a similar MID result to those found by the previous studies.

There is a paucity of literature for TKA and concurrent and predictive validity, but comparable literature for total hip arthroplasty in the Australian population has previously illustrated that the EQ-5D-5L index and the OHS demonstrate strong concurrent validity. The EQ-5D-5L index had similar predictive validity at 6w and 6 m. [11].

Some limitations of this study have to be addressed. There were approximately 21% missing data for patients at six months. Therefore, these patients had to be excluded, introducing a response bias.

Future research should include further validation of these clinically relevant PROMs, as well as perhaps corroboration of the baseline MID for knee arthroplasty patients in Australia.


In conclusion, The EQ-5D-5L index and the Oxford Knee Score demonstrate good concurrent validity in this study. EQ-5D-5L index revealed a large effect size at six weeks and six months postoperatively, but smaller than the OKS at all time points. Both PROMs had adequate responsiveness. However, the OKS outperformed the EQ-5D-5L in all fields. The EQ-VAS had poorer responsiveness than the EQ-5D-5L index, but better predictive validity when used as a stand-alone component.

The EQ-5D-5L index PROM is suitable to quantify general health-related quality of life in the Australian knee arthroplasty patient population. Still, given the OKS superior performance in terms of predictive validity and responsiveness, it should be favoured for use above the EQ-5D-5L. Ideally, both can be used to complement each other with an assessment of a joint specific PROM in OKS and a more generalised health assessment in EQ-5D-5L.

This article establishes a baseline MID for the Australian knee arthroplasty patient population, which can be incorporated into further research or utilised for patient counselling in the perioperative phase.

Availability of data and materials

Data available upon request.



Total knee arthroplasty


Six weeks

6 m:

Six months


Effect size


Standardized response mean


Patient reported outcome measures


Oxford Knee Score


Visual Analogue Scale


Charlson Comorbidity Index


Health Related Quality of Life


Minimally Important Difference


Targeted Maximum Likelihood Estimation


Body mass index


Time Trade-Off


  1. NIH Consensus Statement on total knee replacement. NIH Consens State Sci Statements. 2003;20(1):1–34.

    Google Scholar 

  2. Osteoarthritis

  3. Bourne RB, Chesworth B, Davis A, Mahomed N, Charron K. Comparing patient outcomes after THA and TKA: is there a difference? Clin Orthop Relat Res. 2010;468(2):542–6.

    Article  PubMed  Google Scholar 

  4. Canovas F, Dagneaux L. Quality of life after total knee arthroplasty. Orthop Traumatol Surg Res. 2018;104(1S):S41–6.

    Article  CAS  PubMed  Google Scholar 

  5. EuroQol G. EuroQol–a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.

    Article  Google Scholar 

  6. Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72.

    Article  CAS  PubMed  Google Scholar 

  7. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20(10):1727–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Maignen F, Osipenko L, Pinilla-Dominguez P, Crowe E. Integrating health technology assessment requirements in the clinical development of medicines: the experience from NICE scientific advice. Eur J Clin Pharmacol. 2017;73(3):297–305.

    Article  PubMed  Google Scholar 

  9. Kaambwa B, Bulamu NB, Mpundu-Kaambwa C, Oppong R. Convergent and Discriminant Validity of the Barthel Index and the EQ-5D-3L When Used on Older People in a Rehabilitation Setting. Int J Environ Res Public Health. 2021;18(19):10314. PMID: 34639614; PMCID: PMC8508393.

  10. Guide to the Methods of Technology Appraisal 2013. NICE Process and Methods Guides. London2013. Accessed 9 May 2023.

  11. Lin DY, Cheok TS, Samson AJ, Kaambwa B, Brown B, Wilson C, et al. A longitudinal validation of the EQ-5D-5L and EQ-VAS stand-alone component utilising the Oxford Hip Score in the Australian hip arthroplasty population. J Patient Rep Outcomes. 2022;6(1):71.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Gerlinger C, Bamber L, Leverkus F, Schwenke C, Haberland C, Schmidt G, et al. Comparing the EQ-5D-5L utility index based on value sets of different countries: impact on the interpretation of clinical study results. BMC Res Notes. 2019;12(1):18.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Ernstsson O, Burstrom K, Heintz E, Molsted AH. Reporting and valuing one’s own health: a think aloud study using EQ-5D-5L, EQ VAS and a time trade-off question among patients with a chronic condition. Health Qual Life Outcomes. 2020;18(1):388.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Murray DW, Fitzpatrick R, Rogers K, Pandit H, Beard DJ, Carr AJ, et al. The use of the Oxford hip and knee scores. J Bone Joint Surg Br. 2007;89(8):1010–4.

    Article  CAS  PubMed  Google Scholar 

  15. Conner-Spady BL, Marshall DA, Bohm E, Dunbar MJ, Noseworthy TW. Comparing the validity and responsiveness of the EQ-5D-5L to the Oxford hip and knee scores and SF-12 in osteoarthritis patients 1 year following total joint replacement. Qual Life Res. 2018;27(5):1311–22.

    Article  PubMed  Google Scholar 

  16. Johnston BC, Ebrahim S, Carrasco-Labra A, Furukawa TA, Patrick DL, Crawford MW, et al. Minimally important difference estimates and methods: a protocol. BMJ Open. 2015;5(10):e007953.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Devji T, Carrasco-Labra A, Qasim A, Phillips M, Johnston BC, Devasenapathy N, et al. Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study. BMJ. 2020;369:m1714.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Guyatt GH, Osoba D, Wu AW, Wyrwich KW, Norman GR. Norman GR, Clinical Significance Consensus Meeting G. Methods to explain the clinical significance of health status measures. Mayo Clin Proc. 2002;77(4):371–83.

    Article  PubMed  Google Scholar 

  19. Schmolders J, Friedrich MJ, Michel R, Strauss AC, Wimmer MD, Randau TM, et al. Validation of the Charlson comorbidity index in patients undergoing revision total hip arthroplasty. Int Orthop. 2015;39(9):1771–7.

    Article  PubMed  Google Scholar 

  20. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

    Article  CAS  PubMed  Google Scholar 

  21. Yeo MGH, Goh GS, Chen JY, Lo NN, Yeo SJ, Liow MHL. Are Oxford Hip Score and Western Ontario and McMaster Universities Osteoarthritis Index Useful Predictors of Clinical Meaningful Improvement and Satisfaction After Total Hip Arthroplasty? J Arthroplasty. 2020;35(9):2458–64.

    Article  PubMed  Google Scholar 

  22. Abram SG, Nicol F, Spencer SJ. Patient reported outcomes in three hundred and twenty eight bilateral total knee replacement cases (simultaneous versus staged arthroplasty) using the Oxford Knee Score. Int Orthop. 2016;40(10):2055–9.

    Article  PubMed  Google Scholar 

  23. Mikkelsen M, Gao A, Ingelsrud LH, Beard D, Troelsen A, Price A. Categorization of changes in the Oxford Knee Score after total knee replacement: an interpretive tool developed from a data set of 46,094 replacements. J Clin Epidemiol. 2021;132:18–25.

    Article  PubMed  Google Scholar 

  24. Kang S. Assessing responsiveness of the EQ-5D-3L, the Oxford Hip Score, and the Oxford Knee Score in the NHS patient-reported outcome measures. J Orthop Surg Res. 2021;16(1):18.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Clement ND, MacDonald D, Simpson AH. The minimal clinically important difference in the Oxford knee score and Short Form 12 score after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2014;22(8):1933–9.

    Article  CAS  PubMed  Google Scholar 

  26. Norman R, Cronin P, Viney R. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states. Appl Health Econ Health Policy. 2013;11(3):287–98.

    Article  PubMed  Google Scholar 

  27. Olsen JA, Lamu AN, Cairns J. In search of a common currency: A comparison of seven EQ-5D-5L value sets. Health Econ. 2018;27(1):39–49.

    Article  PubMed  Google Scholar 

  28. Joelson A, Wildeman P, Sigmundsson FG, Rolfson O, Karlsson J. Properties of the EQ-5D-5L when prospective longitudinal data from 28,902 total hip arthroplasty procedures are applied to different European EQ-5D-5L value sets. Lancet Reg Health Eur. 2021;8: 100165.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Devlin NJ, Shah KK, Feng Y, Mulhern B, van Hout B. Valuing health-related quality of life: An EQ-5D-5L value set for England. Health Econ. 2018;27(1):7–22.

    Article  PubMed  Google Scholar 

  30. Rencz F, Lakatos PL, Gulacsi L, Brodszky V, Kurti Z, Lovas S, et al. Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease. Qual Life Res. 2019;28(1):141–52.

    Article  PubMed  Google Scholar 

  31. Golicki D, Niewada M, Buczek J, Karlinska A, Kobayashi A, Janssen MF, et al. Validity of EQ-5D-5L in stroke. Qual Life Res. 2015;24(4):845–50.

    Article  PubMed  Google Scholar 

  32. Weber M, Van Ancum J, Bergquist R, Taraldsen K, Gordt K, Mikolaizak AS, et al. Concurrent validity and reliability of the Community Balance and Mobility scale in young-older adults. BMC Geriatr. 2018;18(1):156.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Lamu AN, Bjorkman L, Hamre HJ, Alraek T, Musial F, Robberstad B. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal. Health Qual Life Outcomes. 2021;19(1):125.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Schober P, Mascha EJ, Vetter TR. Statistics From A (Agreement) to Z (z Score): A Guide to Interpreting Common Measures of Association, Agreement, Diagnostic Accuracy, Effect Size, Heterogeneity, and Reliability in Medical Research. Anesth Analg. 2021;133(6):1633–41.

    Article  PubMed  Google Scholar 

  35. Kamper SJ. Interpreting Outcomes 3-Clinical Meaningfulness: Linking Evidence to Practice. J Orthop Sports Phys Ther. 2019;49(9):677–8.

    Article  PubMed  Google Scholar 

  36. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582–92.

    Article  PubMed  Google Scholar 

  37. Maltenfort MG. The Minimally Important Clinical Difference. Clin Spine Surg. 2016;29(9):383.

    Article  PubMed  Google Scholar 

  38. Jin X, Al Sayah F, Ohinmaa A, Marshall DA, Johnson JA. Responsiveness of the EQ-5D-3L and EQ-5D-5L in patients following total hip or knee replacement. Qual Life Res. 2019;28(9):2409–17.

    Article  PubMed  Google Scholar 

Download references


Not applicable


The authors have no sources of funding to declare for this manuscript.

Author information

Authors and Affiliations



Name: D-Yin Lin, MBBS. Contribution: This author conceived, designed, and submitted to Ethics and Governance the relevant protocols. This author also prepared the drafts, analyzed and prepared the data, and approved and submitted the final manuscript. Name: Tim Soon Cheok, MD. Contribution: This author conceived, assisted with designing, conducted the statistical analysis, critically revised the drafts, and approved the final manuscript.. Name: Billingsley Kaambwa, PhD. contributions This author supervised the statistical analysis, and approved the final manuscript. Name: Anthony J. Samson, BMBS. Contribution: This author conceived, designed and realized the study protocol, supervised the database, realized the study, acquired the data, and approved the final manuscript. Name: Craig Morrison, BMBS. Contributions. This author conceived and designed the study, and approved the final manuscript. Name: Teik Chan, BMBS. Contribution: This author conceived and designed the study, and approved the final manuscript. Name: Hidde M. Kroon, MD, PhD. Contributions. This author conceived, assisted with designing, critically revised the drafts, and approved the final manuscript. Name: Professor Ruurd L. Jaarsma, MD, PhD. Contribution: This author conceived, assisted with designing, realized the study, lended departmental support, revised the drafts, and approved the final manuscript.

Corresponding author

Correspondence to D-Yin Lin.

Ethics declarations

Ethical Approval and Consent to participate

The local Human Research Ethics Committee granted multi-centre approval (SALHN/329.17). Informed consent was obtained from all participants.

Consent for publication

Consent for publication was included in the initial informed consent from all participants. We as an author group also approve this manuscript and give consent for publication.

Competing interests

All authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, DY., Cheok, T.S., Kaambwa, B. et al. Evaluation of the EQ-5D-5L, EQ-VAS stand-alone component and Oxford knee score in the Australian knee arthroplasty population utilising minimally important difference, concurrent validity, predictive validity and responsiveness. Health Qual Life Outcomes 21, 41 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: